Featured

Cancer and other noncommunicable diseases: back on the EU’s health radar? | HCS



Published
Questions addressed:
- Have NCDs treatment and prevention been left aside during the COVID-19 period? If so, what have been the consequences?
- How can new investment into health systems through the Next Generation EU money be used to improve the treatment of NCDs?
- Could Europeans’ increased health attention due to the pandemic lead to healthier habits? Could this result in a decrease in NCDs? Does this make sense given the plurality of causes of NCDs?

With:
John F. Ryan, director, public health, DG SANTE, European Commission
Rui Medeiros, president, Association of European Cancer Leagues
Lobna Salem, regional chief medical officer, developed markets, (North America, Europe, Japan, Australia and New Zealand), Viatris
Jennifer L. Baker, member of the executive committee, European Association for the Study of Obesity

Visit our website: https://www.politico.eu/healthcare-summit/

-------- Social Media --------
Follow us on Twitter: https://twitter.com/POLITICOEurope | https://twitter.com/LivePOLITICO
Follow us on Facebook: https://www.facebook.com/POLITICOeu
Follow us on LinkedIn: https://linkedin.com/company/politico-europe/
Category
Health
Be the first to comment